Status:

RECRUITING

Pharmacist Led Educational Intervention on QOL, Medication Adherence & Satisfaction on Patients With Type 1 DM

Lead Sponsor:

University of Baghdad

Conditions:

Diabetes Mellitus, Type 1

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

There was no previous study in Iraq to evaluate the efficacy of pharmacist-led educational intervention on patient glycemic control, quality of life and medication adherence among type 1 diabetic pati...

Detailed Description

Aim of the Study: The aim of the current study is to evaluate the impact of pharmacist-led educational intervention on glycemic control, quality of life and medication adherence among type 1 diabetic...

Eligibility Criteria

Inclusion

  • \- Patients age ≥ 16 years old who can speak and read the Arabic language.
  • Had been diagnosed with T1DM for at least 6 months ago.
  • Had uncontrolled hyperglycemia (glycosylated hemoglobin HbA1C ≥7% and/or fasting blood glucose \>130 mg/dl)
  • Patients on the same regimen the last 3 months.
  • patients (or parents) acceptance to participate in the study.

Exclusion

  • 1-Patient who have hearing, speech or cognitive deficits that would impair understanding of the questions and receiving the education.
  • 2- Patients with comorbid conditions that may interfere with the study such as asthma, thyroid disorders, adrenal gland disorders, celiac disease, or significant renal impairment.
  • 3-Patients who are taking corticosteroids. 4- Patients who required changing their insulin regimen, increasing the dose \>20% of the previous dose. (21) 5- Patients with conditions that affect red blood cell turnover (hemolytic and other anemias, G-6-PD deficiency, recent blood transfusion, use of drugs that stimulate erythropoiesis, end stage kidney disease and pregnancy.
  • 6-Patients unwilling to participate.

Key Trial Info

Start Date :

February 1 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2024

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06547970

Start Date

February 1 2024

End Date

September 1 2024

Last Update

August 12 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Al-kindy Specialized center for endocrine diseases and diabetes

Baghdad, Iraq, 12221